# Febuxostat Versus Allopurinol Control Trial in Subjects With Gout

> **NCT00102440** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 760 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Febuxostat
- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT00102440
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2004-02
- **Final completion:** 2004-02
- **Target enrollment:** 760 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102440, "Febuxostat Versus Allopurinol Control Trial in Subjects With Gout". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00102440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*